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Abstract
Background: Head and neck cancer incidence is increasing worldwide. Despite overall improvements in survival,
numerous studies suggest worse survival in more disadvantaged populations; however, this literature has not been
systematically reviewed. The aim of this review is to investigate whether lower compared to higher socioeconomic
status (SES) influences survival in head and neck squamous cell cancer (HNSCC) and explore possible explanations
for any relationship found.
Method: A systematic strategy will be used to identify articles, appraise their quality and extract data. Online
databases including MEDLINE, Web of Knowledge, ESBCO Host and Scopus will be used to locate observational
studies of adults with a primary diagnosis of head and neck cancer in EU15+ countries (15 members of the EU,
Australia, Canada, Norway, USA and New Zealand) where the outcomes report associations between SES and
survival. This will be augmented by searching for grey literature and through reference lists. Data will be extracted
using a standardised form. Study quality will be assessed using the Newcastle Ottawa scale and where possible
meta-analysis of the pooled data will be conducted.
Discussion: This review will quantify the association between SES and survival outcomes for adult head and neck
cancer patients in developed countries. The results will help identify gaps in the literature and therefore direct
further novel research in the field. Ultimately, this will inform public policy and strategies to reduce the inequalities
in HNSCC survival.
Systematic review registration: PROSPERO CRD42016037019.
Keywords: Head and neck cancer, Socio-economic status, Socio-economic inequalities, Survival, Systematic review,
Meta-analysis
Background
A large body of literature on health inequalities shows that
more disadvantaged populations are more likely to experi-
ence illnesses and premature death [1]. Socioeconomic
inequalities have been demonstrated in head and neck
cancer incidence (HANC) [2]. However, evidence on the
relationship between social deprivation and HANC sur-
vival has not been comprehensively synthesised.
Collectively, head and neck cancer is the 6th most
common cancer worldwide accounting for 550,000 new
cases per annum and this figure is rising [3, 4]. Overall
and disease-specific survival for head and neck cancer
patients has improved, particularly for human papillo-
mavirus (HPV)-positive oropharyngeal cancer [5, 6].
However, the full extent of this survival benefit has not
been conferred to HPV-negative head and neck squa-
mous cell carcinomas (HNSCC) which tend to affect a
different cohort of patients [7, 8].
In 2013, over 8000 new cases of HNSCC were diag-
nosed in England and Wales with an overall mortality
rate of 13.4% [9]. The estimated cost of HANC hospitali-
sations in the NHS is around £57.1 million per annum
[10]. This debilitating disease also impacts on daily life
long after the initial diagnosis and treatment. In the
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USA, the loss of productivity, as measured by a loss of
earnings, is estimated to be $3.4 billion [11]. The eco-
nomic burden and social burden of HANC falls hardest
on those in lower socio-economic status (SES) groups.
There are several individual studies examining the
link between SES and survival in head and neck cancer
in general and or at specific subsites. Most suggest
there is a strong association between low SES and
worse survival outcomes [12–21]. Using Scottish regis-
try data, Robertson et al. estimated that there was a
27% greater risk of death for those in the most deprived
SES groups compared to the least [12]. Nutting et al.
described that improvements in laryngeal cancer sur-
vival in England and Wales for men from 1985 to 2001
are limited to the most affluent groups [22]. Further-
more, both McDonald et al. and Rachet et al. have
suggested that the absolute differences in survival
between the most and least affluent groups appear to
be increasing [13, 14].
Estimates of the impact of SES on health and neck
cancer survival vary. This may be because studies have
used different designs, measured SES in different ways
and adjusted for different confounding variables (such as
age, sex, race, stage, alcohol and tobacco consumption,
region, income, education and occupation). For instance,
a retrospective cohort study collating evidence from two
oncology studies on non-metastatic head and neck can-
cer by Coyne et al. estimates that the lowest income
groups have a 30% increased risk of HNSCC mortality
whereas a similar study looking into neighbourhood
deprivation in America and its effect on head and neck
cancer outcomes published by Retizel et al. 2012
estimates this to be at 70% [20, 23]. In this review, we
aim to synthesise the available evidence and to explore
reasons for any differences uncovered across the
included studies.
Our review is part of a larger project aimed at better
understanding the relationship between SES and a range
of HNSCC outcomes. Our analyses are informed by the
Diderichsen model of pathways to inequalities in health
(Fig. 1) [24]. In the model, an individual’s social position
leads to differential exposure and vulnerability to risk
factors, for instance tobacco and alcohol in the case of
HNSCC. These processes lead to differential health out-
comes with varying levels of access to health care that
may have differential social consequences on income
and ultimately survival. Similar frameworks have been
utilised to describe inequalities in cancer outcomes in
breast, prostate, cervical and colorectal cancer [25, 26].
The first part of this pathway, the association between
SES and the risk of developing HANC, has been
explored in a systematic review by Conway et al. The
review showed that people in the lowest educational and
income groups had at least a twofold increased risk of
developing HANC [2].
However, there has been no overarching systematic re-
view of the evidence assessing the association between
SES and survival outcomes in HNSCC, and only parts of
the putative causal pathway (as per Fig. 1) have been
explored. The aim of this systematic review is therefore
Fig. 1 Diderichsen model of pathways to health inequalities applied to HNSCC cancer incidence and outcomes [24]
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to investigate whether lower compared to higher SES
influences survival in HNSCC in developed countries
and to explore the variables that may explain any
relationship found. We will assess the magnitude,
statistical significance and associations of the SES
variables with survival. This will help identify any gaps
in the current evidence base and allow us to focus our
public health efforts to reduce the burden of HNSCC.
Methods/design
To improve the transparency and completeness of this
systematic review protocol, a completed copy of the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses for Protocols 2015 (PRISMA-P 2015)
checklist is available as an Additional file 1 [27].
Research question
For individuals from developed countries, does lower
compared to higher socioeconomic status influence sur-
vival in head and neck cancer?
Population
Any individual including and over the age of 18, of any gen-
der from a European Union 15+ (EU15+) country will be
selected. A EU15+ country is any of the first 15 members
of the EU and Australia, Canada, Norway, USA and New
Zealand. A similar set of countries has been used in previ-
ous UK-based comparative health inequality studies [28].
Outcome
The primary outcome of interest is differences in HNSCC
survival between SES groups. This aggregate level data is
measured as univariate and multivariate odds ratios or
hazard ratios with 95% confidence intervals.
Exposure
We will focus on SES measures at individual or aggre-
gate level data by income, education, occupation and
neighbourhood deprivation indices. SES levels will be
measured as per Conway et al. using a five-level ordinal
strata, if possible [29].
Other data
In addition, data on potentially confounding or mediat-
ing factors will be sought, such as alcohol and smoking,
age, sex, marital status, co-morbidities, time to presenta-
tion, stage of presentation and types of surgical and or
medical interventions.
Inclusion/exclusion criteria
The following studies will be included in the review:
○ Observational studies (cross-sectional, ecological,
case-control, cohort (prospective and retrospective)
reporting quantitative results and analysis of
empirical data on association between socioeconomic
status and survival for patients with HNSCC
(ICD C00-C14 and C30-C32).
○ This can be measured at individual or aggregate level
by occupation, income, education, employment or
neighbourhood deprivation where the outcome
is an odds ratio or hazards ratio with measures
of variance.
○ EU15+ countries.
○ Publications written in or translated into English,
reporting on human subjects and published from
1990, inclusive.
The following studies will be excluded from the
review. Those focussing on:
○ Loco-regional recurrence of head and neck cancer
○ Second primary HNSCC
○ Outcomes for patients primarily presenting with
cancers of the nasopharynx, thyroid or oesophagus
○ Subjects <18 years of age
Search strategy
A systematic strategy will be used to identify relevant
articles, assess their eligibility and appraise their quality.
This will be achieved by searching databases, the
reference lists for any studies accepted for inclusion and
grey literature.
Electronic searching of four databases will be per-
formed: MEDLINE, Web of Knowledge, ESBCO Host
and Scopus. These databases were discussed within the
research collaboration and were identified as the most
likely to yield relevant papers. We will include data from
the 20 economically developed EU 15+ nations outlined
in Appendix 1.
The search terms outlined in Appendix 2 were piloted
prior to selection. They comprise of specific head and
neck cancers, inequality terms and developed countries
of interest. Relevant terms were identified during an
initial scoping literature review of the topic.
Where possible, terms will be exploded to widen the
search. Terms will be added as keywords if they cannot
be exploded or if the exploded terms are not relevant to
the research question. Truncation and proximity opera-
tors will also be applied as necessary to broaden the
search. For consistency, the same terms will be inputted
for each database, e.g. Scopus and Web of Science; how-
ever, as the functionality of each database is different,
the terms have been adapted for correct use in each.
The same filters will be applied to all included data-
bases as per the inclusion criteria. This will ensure arti-
cles are in English, on human subjects and investigating
the influence of SES on HNSCC from 1990 onwards. As
Taib et al. Systematic Reviews  (2017) 6:151 Page 3 of 6
social conditions change over time, limiting the litera-
ture to this time period will ensure that publications are
as relevant as possible to the present day. The search
will be broad as studies examining the incidence of
HNSCC may also examine the impact of SES on survival
as a secondary outcome. The searches will be re-run
after the initial data extraction period so any further
studies are included. The remaining publications will
then be exported to a referencing software and com-
bined so that any duplicates are removed. These will
then be screened as per the eligibility criteria.
Titles, abstracts and full texts will be screened inde-
pendently by one author (BGT). The second reviewer will
screen a 10% sample of the extracted papers—at title, ab-
stract and full text stages (SP) to ensure consistency in the
application of the eligibility criteria. If it is not clear from
the title or abstract whether analyses by SES have been
performed, the full text of the article will be retrieved and
examined. All full text studies will be reviewed independ-
ently by two reviewers (BGT and SP) to ensure that the
studies meet the inclusion and exclusion criteria. Any dis-
crepancies either at the title, abstract or full-text phase will
be discussed (DTR and TMJ) until an agreement is
reached between all reviewers.
Another strategy will consist of searching through the
reference list of articles that may have been missed by
electronic database searches. Studies of interest will have
their titles and abstracts analysed and screened as per
our inclusion and exclusion criteria. We will also use the
forward citation map to locate newer articles which have
cited the older study identified. The full text for those
articles that meet the initial inclusion criteria will be
screened (BGT and JR) and any discrepancies discussed
between the reviewers.
Finally, we will further augment our search by search-
ing for grey literature. We will do this by entering the
terms “head and neck cancer”, “socioeconomic”, “social
class” and “deprivation” into the Google internet search
engine and Google Scholar search application and asses-
sing the first 100 results including reports from cancer
registries, HANC audit reports, published abstracts and
theses. In a similar manner, we will also search Open-
Grey a repository for grey literature in Europe. Again,
this will be performed independently by two reviewers
(BGT and JR), and any disagreements will be resolved
through discussion with the wider group.
Quality assessment
Risk of bias and quality assessment will be conducted by
two reviewers (BGT and JR). Methodological quality of
the included studies will be assessed using the
Newcastle-Ottawa Scale and/or Cochrane risk of bias
framework [30, 31]. Any discrepancies identified will be
discussed and reviewed by the review team.
Data analysis and synthesis
To organise this data and to aid comparison between
studies, tables will be created from which extracted data
will be placed in a standardised manner. A proforma has
been developed and piloted on three studies. Information
to be extracted includes: year of publication, country, hy-
pothesis, study design, level of analysis, sample size, age, re-
cruitment period, SES variable measured, health measure
outcome(s), tool used to measure the outcome, covariates
analyses, significant and non-significant results, adjusted
and unadjusted odds ratio/hazard ratio (OR/HR) for all
cause and HNSCC-specific mortality, confidence intervals,
conclusions, comments on limitations and quality assess-
ment. Extracted data will be checked by one other reviewer
(JR). We are anticipating to be able to explore heterogeneity
and undertake analyses to explore the impact of potentially
moderating factors such as age, sex, performance status,
site, alcohol consumption, smoking, grade, stage, treatment
employed, SES measures and neighbourhood deprivation.
Harvest plots maybe used where appropriate to display and
summarise the results of the studies and to display the im-
pact of moderating factors subgrouping graphically [32].
Where possible meta-analysis of extracted data will be
undertaken via the Mantel-Haenszel method using a
fixed-effects model as default, unless significant hetero-
geneity is present, in which case a random-effects model
will be used. HRs will be calculated with 95% confidence
intervals. A p value of <0.05 will be regarded as signifi-
cant. Heterogeneity will be assessed using the I-squared
statistic. We will undertake sensitivity analysis on the
basis of study quality.
Dissemination
The systematic review will be submitted for publication.
The findings will be presented at national and inter-
national conferences. It will also be presented locally to
help inform the council and public health initiatives.
Discussion
This protocol describes how this systematic review will
determine the impact of SES on the survival outcomes
of adult HNSCC patients. Using the Diderichsen model
(Fig. 1), we will identify the key variables and pathways
that generate inequalities in survival in HANC.
In the UK, the gender-specific inequality gaps in survival
between certain HANCs are the widest of any cancer [14].
Furthermore, the incidence of HANC is increasing and
stark geographical inequalities exist in the UK [29]. This,
coupled with a recent survival benefit generally limited to
the more affluent groups, highlights the necessity of better
understanding of SES and HNSCC [22].
We hope that the results of this review will identify
potential targets for intervention to reduce inequalities
in HNSCC outcomes.
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